#ORPH Open Orphan – Imutex Vaccine Phase I Study Results

AGS-v PLUS mosquito vaccine candidate shows favourable safety, tolerability, and immunogenicity results Results to be presented at the American Society of Tropical Medicine and Hygiene Annual Meeting   Open Orphan plc (AIM: ORPH) announces that data from the first-in-human Phase I clinical study evaluating the safety, immunogenicity, and in vitro efficacy of AGS-v PLUS,  Imutex Limited’s (“Imutex’) mosquito saliva […]

#MNRG MetalNRG – BritNRG Limited Update

MetalNRG (LON:MNRG), the natural resources and energy investment company, announces an update on its joint venture, BritNRG Limited, and a dispute that has arisen with a former director of MetalNRG, Mr Pierpaolo Rocco, and BritEnergy Holdings LLP, the partner in the BritNRG Limited joint venture, in connection with which, it is now apparent that Mr Rocco is […]

#POLB Poolbeg Pharma – Update on POLB 001 Clinical Development

18 November 2021 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’) a clinical stage infectious disease pharmaceutical company with a capital light clinical model, is pleased to provide an update on the clinical development progress of its lead asset, POLB 001, a small molecule immunomodulator for the treatment of severe influenza. The Company intends to […]

#POW Power Metal Plc – Financing Raises £1,050,000

Power Metal Resources plc (LON:POW), the London listed exploration company seeking large-scale metal discoveries across its global project portfolio, announces the Company has raised £1.05 million through a placing  of new ordinary shares of 0.1 pence each in the Company as detailed below (the “Placing”).   HIGHLIGHTS: – Power Metal raised £1.05 million at the closing market […]

#ORPH Open Orphan – £1.5m Contract renewal for Venn Life Sciences

Open Orphan (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that Venn Life Sciences (“Venn”), a subsidiary of Open Orphan, has signed a contract renewal with a major global pharmaceutical client worth £1.5m over two years. The renewed contract will commence in January 2022, with […]

#POW Power Metal Resources – Notification of Major Shareholding

Power Metal Resources TR-1: Standard form for notification of major holdings – Thor Mining Plc now holds 3.62% (1,341,839,837 shares)   TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer […]

Power Metal Resources #POW – Uranium Portfolio Expansion – Athabasca Basin

Power Metal Resources PLC (LON:POW) the London listed exploration company seeking large-scale metal discoveries across its global project portfolio announces a uranium exploration portfolio expansion at its 100% owned interests surrounding the Athabasca Basin in northern Saskatchewan, Canada. PORTFOLIO HIGHLIGHTS: – Total land holdings surrounding the Athabasca Basin have now been increased by 144.84 km2to a […]

#POW Power Metal Resources – Katoro Gold Update – Haneti Nickel Project

Power Metal Resources PLC (LON:POW) the London listed exploration company seeking large-scale metal discoveries across its global project portfolio,  draws  investors’ attention to the announcement issued today by Katoro Gold plc (LON: KAT)(“Katoro Gold”)(“Katoro”). The Katoro announcement may be viewed through the following link: https://polaris.brighterir.com/public/katoro_gold/news/rns/story/wklg9dx   Paul Johnson, Chief Executive Officer of Power Metal Resources […]